RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4639
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_0931200; Gene model (P.falciparum): PF3D7_1116800; Gene product: heat shock protein 101 | chaperone protein ClpB2 (HSP101)
Name tag: HA/streptavidine tag
Transgene
Transgene not Plasmodium: KAHRP leader, including its hydrophobic signal sequence and PEXEL motif, conjugated to GFP
Promoter: Gene model: PBANKA_0711900; Gene model (P.falciparum): PF3D7_0818900; Gene product: heat shock protein 70 (HSP70)
3'UTR: Gene model: Not available; Gene product: Not available
Insertion locus: Gene model: PBANKA_0931200; Gene product: heat shock protein 101 | chaperone protein ClpB2 (HSP101)
Phenotype Asexual bloodstage;
Last modified: 10 June 2019, 16:54
  *RMgm-4639
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 31164473
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA cl15cy1
Other information parent lineA reference wild type clone from the ANKA strain of P. berghei (PubMed: PMID: 17406255).
The mutant parasite was generated by
Name PI/ResearcherMatthews KM, de Koning-Ward TF
Name Group/DepartmentSchool of Medicine
Name InstituteDeakin University
CityWaurn Ponds, Victoria
CountryAustralia
Name of the mutant parasite
RMgm numberRMgm-4639
Principal namePb101HA/K(L)GFP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageSee additional information
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The protein expresses a C-terminal HA/streptavidine tagged form of HSP101. In addition, it expresses a reporter comprised of the N-terminal leader of the knob-associated histidine-rich protein (KAHRP leader [KL]), including its hydrophobic signal sequence and PEXEL motif, conjugated to GFP and placed under the transcriptional control of the constitutive HSP70 promoter

Protein (function)
Plasmodium parasites must export proteins into their erythrocytic host to survive. Exported proteins must cross the parasite plasma membrane (PPM) and the parasitophorous vacuolar membrane (PVM) encasing the parasite to access the host cell. Crossing the PVM requires protein unfolding and passage through a translocon, the Plasmodium translocon of exported proteins (PTEX). In this study, we provide the first direct evidence that heat shock protein 101 (HSP101), a core component of PTEX, unfolds proteins for translocation across the PVM by creating transgenic Plasmodium parasites in which the unfoldase and translocation functions of HSP101 have become uncoupled.

Phenotype
To study HSP101 function and dissect how it contributes to protein export, two transgenic parasite lines were generated in the rodent malaria parasite Plasmodium berghei, termed Pb101HA/KLGFP and Pb101HA+2AmCh/KLGFP. To create these parasites, the endogenous hsp101 locus was replaced with full-length hsp101 fused at its 3' end to a triple hemagglutinin (HA) and streptavidin epitope and incorporating a heterologous 3' untranslated region (3' UTR).
Previous studies of Plasmodium falciparum and P. berghei have demonstrated that HSP101 can accommodate these tags at its C terminus without impacting parasite growth or protein export. Utilizing the same construct, an exported reporter cassette was incorporated downstream of the hsp101 locus of both lines. This reporter comprised the N-terminal leader of the knob-associated histidine-rich protein (KAHRP leader [KL]), including its hydrophobic signal sequence and PEXEL motif, conjugated to GFP and placed under the transcriptional control of the constitutive HSP70 promoter . The Pb101HA+2AmCh/KLGFP line also harbors an mCherry coding sequence, which is separated from the HSP101 coding sequence by the foot and mouth disease virus 2A skip peptide, to produce a polycistronic HSP101-HA-2A-mCherry mRNA .
We anticipated that the 2A skip peptide would produce separate HSP101-HA and mCherry proteins. However, Western blot analysis of HSP101 revealed that separation by the 2A peptide was inefficient in the Pb101HA2AmCh/KLGFP line. Instead, two forms of HSP101 protein were generated, corresponding to HSP101-HA alone (Pb101HA) or a larger HSP101-HA2A-mCherry protein (Pb101HA2AmCh).
We have previously published a similar approach to generate parasite expressing PbEXP2-2A-FRT in which EXP2 and mCherry were also generated from a polycistronic mRNA. In that case, cleavage of the 2A peptide was very efficient, giving rise to separate EXP2 and mCherry polypeptides.
Since HSP101 oligomerizes into hexamers to associate with the PTEX complex, we examined whether conjugation of HSP101 with a bulky 28-kDa mCherry protein impaired the ability of HSP101 to be incorporated into PTEX. Immunoprecipitation of mCherry using red fluorescence protein (RFP)-TRAP resulted in the pulldown of Pb101HA2AmCh together with Pb101HA. Importantly, Pb101HA2AmCh also immunoprecipitated with EXP2. Together, this indicates that Pb101HA2AmCh is incorporated into HSP101 hexamers and into the PTEX complex.
We then examined the solubility of Pb101HA2AmCh using carbonate extraction assays. HSP101 is peripherally associated with the PVM and thus is normally released into the supernatant fraction only after treatment with carbonate. We found that Pb101HA2AmCh has a solubility profile similar to that of Pb101HA, indicating that the addition of mCherry to Pb101HA did not change the solubility profile of the protein. This result is consistent with Pb101HA2AmCh incorporating into the PTEX complex at the PVM, rather than being present as a soluble protein in the PV, in which case HSP101HA2AmCh would be present in the hypotonic supernatant fraction.
Ii was further shown that:
- Pb101HA2AmCh/KLGFP parasites fail to export the GFP reporter and show reduced parasite growth.
- Pb101HA2AmCh/KLGFP can export native proteins.
- Soluble reporter proteins are directly affected by the efficiency of HSP101 function.
- PEXEL proteins with TMDs are exported without unfolding by PTEX

Additional information
From the paper:
In this study, we provide the first direct evidence that heat shock protein 101 (HSP101), a core component of PTEX, unfolds proteins for translocation across the PVM by creating transgenic Plasmodium parasites in which the unfoldase and translocation functions of HSP101 have become uncoupled. Strikingly, while these parasites could export native proteins, they were unable to translocate soluble, tightly folded reporter proteins bearing the Plasmodium export element (PEXEL) across the PVM into host erythrocytes under the same conditions. In contrast, an identical PEXEL reporter protein but harboring a transmembrane domain could be exported, suggesting that a prior unfolding step occurs at the PPM. Together, these results demonstrate that the export of parasite proteins is dependent on how these proteins are presented to the secretory pathway before they reach PTEX as well as their folded status. Accordingly, only tightly folded soluble proteins secreted into the vacuolar space and not proteins containing transmembrane domains or the majority of erythrocyte-stage exported proteins have an absolute requirement for the full unfoldase activity of HSP101 to be exported.

Other mutants


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0931200
Gene Model P. falciparum ortholog PF3D7_1116800
Gene productheat shock protein 101 | chaperone protein ClpB2
Gene product: Alternative nameHSP101
Details of the genetic modification
Name of the tagHA/streptavidine tag
Details of taggingC-terminal
Additional remarks: taggingThe protein expresses a C-terminal HA/streptavidine tagged form of HSP101.
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor targeted integration of DNA constructs into the endogenous P. berghei hsp101 locus, the C-terminal end of hsp101 and the 3'UTR were PCR amplified from P. berghei ANKA genomic DNA (gDNA) using gene-specific primers 461/462 and 459/460, respectively. The resulting fragments were digested with MluI/SacII and SacII/SphI and cloned into the corresponding sites of the previously described plasmid, pEXP2-2A-FRT. This plasmid contains the C-terminal end of exp2 fused to sequences encoding a 2A skip peptide and mCherry reporter followed by a heterologous 3'UTR as well as an exported reporter, KAHRPL-GFP, under the transcriptional control of the HSP70 promoter. The construction of the KLGFP expression cassette has been described previously. The final engineered construct was termed p101HA+2AmCh/KLGFP. A control construct, termed p101HA/KLGFP was made, in which the 2A-mCherry sequences were deleted. Both plasmids were sequenced and linearized with SacII prior to transfection.
Additional plasmids were constructed using the parent plasmids described above with variations made to the reporter cassette. (i) To assess the trafficking of a tightly folded exported protein under the KAHRP leader sequence, the P. falciparum ubiquitin-60S ribosomal protein L40 (PF3D7_1365900) was amplified from P. falciparum gDNA using oligonucleotides DO617/DO618. Replacement of the isoleucine amino acids at positions 3 and 13 with alanine were made using the QuikChange II site-directed mutagenesis kit (Agilent) and oligonucleotides DO619/D0620. Fragments were digested with AvrII/AgeI and cloned into the corresponding sites of parent plasmids Pb101HA/KLGFP and Pb101HA+2AmCh/KLGFP. To enable biochemical measurement of the reporter wild-type and mutated ubiquitin proteins, the sequences encoding nanoluciferase (NLuc) were PCR amplified from pNL1 (Promega) using oligonucleotides DO749/DO750, and the resulting products were digested with AgeI/MluI and cloned in the corresponding sites of Pb101HA/KLGFP and Pb101HA+2AmCh/KLGFP in place of GFP. These four additional plasmids, termed Pb101HA/KLUbNL, Pb101HA/KLUbMNL, Pb101HA+2AmCh/KLUbNL, and Pb101HA+2AmCh/KLUbMNL were sequenced and linearized with SacII prior to transfection. (ii) To assess the trafficking of an exported protein containing a transmembrane domain (TMD), the TMD-positive CP1 protein was amplified from P. berghei gDNA using oligonucleotides DO595 and DO596. A truncated version of CP1, which was missing the C-terminal TMD was engineered using oligonucleotides DO595 and DO597. The CP1 and CPΔTM PCR products were digested with XhoI/AvrII and cloned into the corresponding sites of p101HA/KLGFP and p101HA+2AmCh/KLGFP. The four final constructs were designated Pb101HA/CP1-GFP, Pb101HA/CP1ΔTMGFP, Pb101HA+2AmCh/CP1-GFP, and Pb101HA+2AmCh/CPΔTM. All constructs were sequenced and linearized with SacII prior to transfection into P. berghei.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameKAHRP leader, including its hydrophobic signal sequence and PEXEL motif, conjugated to GFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor targeted integration of DNA constructs into the endogenous P. berghei hsp101 locus, the C-terminal end of hsp101 and the 3'UTR were PCR amplified from P. berghei ANKA genomic DNA (gDNA) using gene-specific primers 461/462 and 459/460, respectively. The resulting fragments were digested with MluI/SacII and SacII/SphI and cloned into the corresponding sites of the previously described plasmid, pEXP2-2A-FRT. This plasmid contains the C-terminal end of exp2 fused to sequences encoding a 2A skip peptide and mCherry reporter followed by a heterologous 3'UTR as well as an exported reporter, KAHRPL-GFP, under the transcriptional control of the HSP70 promoter. The construction of the KLGFP expression cassette has been described previously. The final engineered construct was termed p101HA+2AmCh/KLGFP. A control construct, termed p101HA/KLGFP was made, in which the 2A-mCherry sequences were deleted. Both plasmids were sequenced and linearized with SacII prior to transfection.
Additional plasmids were constructed using the parent plasmids described above with variations made to the reporter cassette. (i) To assess the trafficking of a tightly folded exported protein under the KAHRP leader sequence, the P. falciparum ubiquitin-60S ribosomal protein L40 (PF3D7_1365900) was amplified from P. falciparum gDNA using oligonucleotides DO617/DO618. Replacement of the isoleucine amino acids at positions 3 and 13 with alanine were made using the QuikChange II site-directed mutagenesis kit (Agilent) and oligonucleotides DO619/D0620. Fragments were digested with AvrII/AgeI and cloned into the corresponding sites of parent plasmids Pb101HA/KLGFP and Pb101HA+2AmCh/KLGFP. To enable biochemical measurement of the reporter wild-type and mutated ubiquitin proteins, the sequences encoding nanoluciferase (NLuc) were PCR amplified from pNL1 (Promega) using oligonucleotides DO749/DO750, and the resulting products were digested with AgeI/MluI and cloned in the corresponding sites of Pb101HA/KLGFP and Pb101HA+2AmCh/KLGFP in place of GFP. These four additional plasmids, termed Pb101HA/KLUbNL, Pb101HA/KLUbMNL, Pb101HA+2AmCh/KLUbNL, and Pb101HA+2AmCh/KLUbMNL were sequenced and linearized with SacII prior to transfection. (ii) To assess the trafficking of an exported protein containing a transmembrane domain (TMD), the TMD-positive CP1 protein was amplified from P. berghei gDNA using oligonucleotides DO595 and DO596. A truncated version of CP1, which was missing the C-terminal TMD was engineered using oligonucleotides DO595 and DO597. The CP1 and CPΔTM PCR products were digested with XhoI/AvrII and cloned into the corresponding sites of p101HA/KLGFP and p101HA+2AmCh/KLGFP. The four final constructs were designated Pb101HA/CP1-GFP, Pb101HA/CP1ΔTMGFP, Pb101HA+2AmCh/CP1-GFP, and Pb101HA+2AmCh/CPΔTM. All constructs were sequenced and linearized with SacII prior to transfection into P. berghei.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0711900
Gene Model P. falciparum ortholog PF3D7_0818900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionInsertion locus
Gene Model of Parasite PBANKA_0931200
Gene productheat shock protein 101 | chaperone protein ClpB2
Gene product: Alternative nameHSP101
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4